29 January 2020 - Interactive tool offers information on ARVs eligible for purchase under the President’s Emergency Plan for AIDS Relief program.
Today, the U.S. FDA announced the launch of an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program.
This launch is an important step in our ongoing commitment to address the global HIV epidemic and is consistent with our efforts to modernise and improve access to information and unleash the power of data.